Are there candidates for high-dose chemotherapy in ovarian carcinoma?

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

<p>Abstract</p> <p>Background</p> <p>Prognosis of advanced ovarian carcinomas (AOC) remains poor with a 5-year survival of 30%. Benefit from high-dose chemotherapy (HDC) in this disease has not been demonstrated to date.</p> <p>Methods</p> <p>To...

Full description

Bibliographic Details
Main Authors: Sabatier Renaud, Gonçalves Anthony, Bertucci François, Capiello Maria-Antonietta, Rousseau Frédérique, Lambaudie Eric, Chabannon Christian, Viens Patrice, Extra Jean-Marc
Format: Article
Language:English
Published: BMC 2012-10-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Ovarian carcinomas
Prognosis
High dose chemotherapy
Stem cell support
Online Access:http://www.jeccr.com/content/31/1/87

Internet

http://www.jeccr.com/content/31/1/87

Similar Items